Fundamental Research and Analysis of India Pharmaceutical Sector

Ancy Varghese; Aneena K Santhosh; Anjana K M; Reena Francis

doi:10.34293/sijash.v12iS1-June.9127

Ancy Varghese B.Com. Final Year Student, Bharata Mata College (Autonomous), Thrikkakara, Edappally, Kochi, Kerala
Aneena K Santhosh B.Com. Final Year Student, Bharata Mata College (Autonomous), Thrikkakara, Edappally, Kochi, Kerala
Anjana K M B.Com. Final Year Student, Bharata Mata College (Autonomous), Thrikkakara, Edappally, Kochi, Kerala
Reena Francis Assistant Professor, Department of Commerce (Computer Applications), Bharata Mata College (Autonomous), Thrikkakara, Edappally, Kochi, Kerala

DOI: https://doi.org/10.34293/sijash.v12iS1-June.9127

Keywords: Pharmaceutical Sector, Stakeholders, Altman z Score, Fundamental Analysis, Research and Development

Abstract

A brief analysis of the Indian pharmaceutical industry’s financial health using the Altman Z- Score model. This study’s objective is to evaluate the financial stability, growth potential, and investment potential of three significant companies: Cipla, Sun Pharma, and Dr. Reddy’s Laboratories. Studies that concentrate on elements like R&D,operational efficiency and profitability demonstrate strength of Indian pharmaceutical business. Important conclusions from a number of studies show the industry’s adaptability and growth potential, which are fuelled by innovation and market expansion.